Skip Navigation

This Article
Right arrow Print PDF (1095K)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (25)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Dandoy-Dron, F.
Right arrow Articles by Bucchini, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dandoy-Dron, F.
Right arrow Articles by Bucchini, D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, 1991, Vol. 19, No. 18 4925-4929
© 1991


MOLECULAR BIOLOGY

Regulatory regions of rat insulin I gene necessary for expression in transgenic mice

Françoise Dandoy-Dron, Eliane Monthioux, Jacques Jami and Danielle Bucchini

Institut Jacques Monod, Unité INSERM 257, Université Paris VII 75251 Paris Cedex 05, France

Received June 14, 1991. Accepted August 13, 1991.

Ten transgenic mouse lines harboring the –346/–103 fragment of the rat insulin I enhancer linked to a eterologous promoter and a reporter gene (Elns-Ptk-CAT construct) were produced. Expression of the hybrid transgene was essentially observed in pancreas and to a lesser extent in brain. These results Indicate that the rat insulin I promoter is dispensable for pancreatic expression. This insulin gene sequence is the shortest fragment described as conferring tissue-specific expression in transgenic mice. Two short homologous sequences in the rat insulin I enhancer fragment used, IEB2 and IEB1, have been described as playing a dominant role In the regulation of HIT hamster insulinoma cell-specific transcription of the insulin gene (1). We investigated whether the combination of IEB2 and IEB1 sequences is sufficient to confer specific expression in transgenic mice to a IEB2-IEB1-Ptk-CAT gene construct. No CAT activity was observed neither in pancreas nor In any other organ examined in 19 different transgenic mice. Moreover In transient expression experiments in RIN2A rat insulinoma cells, the IEB sequences had a very weak or no enhancer activity. These observations contribute to the conclusion that DNA regulatory elements other than the IEB sequences are necessary for gene expression in vivo.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
S. C. Martinez, K. Tanabe, C. Cras-Meneur, N. A. Abumrad, E. Bernal-Mizrachi, and M. A. Permutt
Inhibition of Foxo1 Protects Pancreatic Islet {beta}-Cells Against Fatty Acid and Endoplasmic Reticulum Stress-Induced Apoptosis
Diabetes, April 1, 2008; 57(4): 846 - 859.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. C. Koster, M. S. Remedi, R. Masia, B. Patton, A. Tong, and C. G. Nichols
Expression of ATP-Insensitive KATP Channels in Pancreatic {beta}-Cells Underlies a Spectrum of Diabetic Phenotypes
Diabetes, November 1, 2006; 55(11): 2957 - 2964.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
J. Le Lay and R. Stein
Involvement of PDX-1 in activation of human insulin gene transcription
J. Endocrinol., February 1, 2006; 188(2): 287 - 294.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Iype, J. Francis, J. C. Garmey, J. C. Schisler, R. Nesher, G. C. Weir, T. C. Becker, C. B. Newgard, S. C. Griffen, and R. G. Mirmira
Mechanism of insulin Gene Regulation by the Pancreatic Transcription Factor Pdx-1: APPLICATION OF PRE-mRNA ANALYSIS AND CHROMATIN IMMUNOPRECIPITATION TO ASSESS FORMATION OF FUNCTIONAL TRANSCRIPTIONAL COMPLEXES
J. Biol. Chem., April 29, 2005; 280(17): 16798 - 16807.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Alba, M. C. Puertas, J. Carrillo, R. Planas, R. Ampudia, X. Pastor, F. Bosch, R. Pujol-Borrell, J. Verdaguer, and M. Vives-Pi
IFN{beta} Accelerates Autoimmune Type 1 Diabetes in Nonobese Diabetic Mice and Breaks the Tolerance to {beta} Cells in Nondiabetes-Prone Mice
J. Immunol., December 1, 2004; 173(11): 6667 - 6675.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Le Lay, T.-a. Matsuoka, E. Henderson, and R. Stein
Identification of a Novel PDX-1 Binding Site in the Human Insulin Gene Enhancer
J. Biol. Chem., May 21, 2004; 279(21): 22228 - 22235.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Dumonteil, B. Laser, I. Constant, and J. Philippe
Differential Regulation of the Glucagon and Insulin I Gene Promoters by the Basic Helix-Loop-Helix Transcription Factors E47 and BETA2
J. Biol. Chem., August 7, 1998; 273(32): 19945 - 19954.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Pelegrin, J. C. Devedjian, C. Costa, J. Visa, G. Solanes, A. Pujol, G. Asins, A. Valera, and F. Bosch
Evidence from Transgenic Mice That Interferon-beta May Be Involved in the Onset of Diabetes Mellitus
J. Biol. Chem., May 15, 1998; 273(20): 12332 - 12340.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. M.M. Stellrecht, F. J. DeMayo, M. J. Finegold, and M.-J. Tsai
Tissue-specific and Developmental Regulation of the Rat Insulin II Gene Enhancer, RIPE3, in Transgenic Mice
J. Biol. Chem., February 7, 1997; 272(6): 3567 - 3572.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. H. Harrington and A. Sharma
Transcription Factors Recognizing Overlapping C1-A2 Binding Sites Positively Regulate Insulin Gene Expression
J. Biol. Chem., January 5, 2001; 276(1): 104 - 113.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.